Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients With Intermediate-Risk Acute Myelogenous Leukemia in First Complete Remission

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1637

Related search